KRISTENSEN, Steen D., Kristina G. LAUT, Jean FAJADET, Zuzana KAIFOSZOVA, Petr KALA, Mario Di CARLO, William WIJNS, Peter CLEMMENSEN, Vaja AGLADZE, Loizos ANTONIADES, Khalid F. ALHABIB, Menko-Jan De BOER, MarcJ. CLAEYS, Dan DELEANU, Dariusz DUDEK, Andrejs ERGLIS, Martine GILARD, Omer GOKTEKIN, Giulio GUAGLIUMI, Thorarinn GUDNASON, Kim Wadt HANSEN, Kurt HUBER, Stefan JAMES, Tomáš JANOTA, Siobhan JENNINGS, Olli KAJANDER, John KANAKAKIS, Kiril K. KARAMFILOFF, Sasko KEDEV, Ran KORNOWSKI, Peter F. LUDMAN, Béla MERKELY, Davor MILICIC, Ruslan NAJAFOV, Francesca A. NICOLINI, Marko NOČ, Miodrag OSTOJIC, Hélder PEREIRA, Dragana RADOVANOVIC, Manel SABATÉ, Mohamed SOBHY, Maxim SOKOLOV, Martin STUDENCAN, Ibrahim TERZIC, Steffen WAHLER and Petr WIDIMSKY. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. European heart journal. Oxford: Oxford University Press, 2014, vol. 35, No 29, p. 1957-1970. ISSN 0195-668X. Available from: https://dx.doi.org/10.1093/eurheartj/eht529.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries
Authors KRISTENSEN, Steen D. (208 Denmark), Kristina G. LAUT (208 Denmark), Jean FAJADET (250 France), Zuzana KAIFOSZOVA (826 United Kingdom of Great Britain and Northern Ireland), Petr KALA (203 Czech Republic, guarantor, belonging to the institution), Mario Di CARLO (826 United Kingdom of Great Britain and Northern Ireland), William WIJNS (56 Belgium), Peter CLEMMENSEN (208 Denmark), Vaja AGLADZE (268 Georgia), Loizos ANTONIADES (196 Cyprus), Khalid F. ALHABIB (682 Saudi Arabia), Menko-Jan De BOER (528 Netherlands), MarcJ. CLAEYS (56 Belgium), Dan DELEANU (642 Romania), Dariusz DUDEK (616 Poland), Andrejs ERGLIS (440 Lithuania), Martine GILARD (250 France), Omer GOKTEKIN (792 Turkey), Giulio GUAGLIUMI (380 Italy), Thorarinn GUDNASON (372 Ireland), Kim Wadt HANSEN (208 Denmark), Kurt HUBER (40 Austria), Stefan JAMES (752 Sweden), Tomáš JANOTA (203 Czech Republic), Siobhan JENNINGS (372 Ireland), Olli KAJANDER (246 Finland), John KANAKAKIS (300 Greece), Kiril K. KARAMFILOFF (100 Bulgaria), Sasko KEDEV (807 North Macedonia), Ran KORNOWSKI (376 Israel), Peter F. LUDMAN (826 United Kingdom of Great Britain and Northern Ireland), Béla MERKELY (348 Hungary), Davor MILICIC (191 Croatia), Ruslan NAJAFOV (31 Azerbaijan), Francesca A. NICOLINI (674 San Marino), Marko NOČ (705 Slovenia), Miodrag OSTOJIC (688 Serbia), Hélder PEREIRA (620 Portugal), Dragana RADOVANOVIC (756 Switzerland), Manel SABATÉ (724 Spain), Mohamed SOBHY (818 Egypt), Maxim SOKOLOV (804 Ukraine), Martin STUDENCAN (703 Slovakia), Ibrahim TERZIC (70 Bosnia and Herzegovina), Steffen WAHLER (276 Germany) and Petr WIDIMSKY (203 Czech Republic).
Edition European heart journal, Oxford, Oxford University Press, 2014, 0195-668X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 15.203
RIV identification code RIV/00216224:14110/14:00075579
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1093/eurheartj/eht529
UT WoS 000342232100010
Keywords in English Primary percutaneous coronary intervention; STEMI; Treatment variation; Europe
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 23/10/2014 14:01.
Abstract
Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.
PrintDisplayed: 7/10/2024 06:30